RESUMEN
The aim of this study was to explore the physicochemical parameters that influence coaggregation between the freshwater bacteria Sphingomonas natatoria 2.1 and Micrococcus luteus 2.13. Using visual coaggregation assays, the effect of different buffers, solutions of differing ionic strength, pH, temperature, and viscosity on the degree of coaggregation was assessed. Coaggregation occurred maximally in distilled water but was inhibited when coaggregates were suspended in a commonly-used oral bacterial coaggregation buffer, saline solutions, and Tris-Cl buffers. Coaggregation was weakly expressed in standard laboratory buffers. The ionic strength of inorganic salt solutions required to inhibit coaggregation depended upon the inorganic salt being tested. Coaggregation occurred at a pH of 3-10, between 5 and 80°C and was inhibited in solutions with a viscosity of 22.5 centipoises at 20°C. Inhibition of coaggregation with NaCl impaired biofilm development. When developing buffers to test for coaggregation, the natural liquid environment should be considered. Coaggregation between S. natatoria 2.1 and M. luteus 2.13 is only affected by physicochemical conditions beyond those typically found in natural freshwater ecosystems. Such a robust ability to coaggregate may enhance the ability of S. natatoria 2.1 and M. luteus 2.13 to develop a niche in freshwater biofilms.
Asunto(s)
Biopelículas , Agua Dulce/microbiología , Micrococcus luteus , Sphingomonas , Animales , Adhesión Bacteriana/efectos de los fármacos , Adhesión Bacteriana/fisiología , Biopelículas/efectos de los fármacos , Biopelículas/crecimiento & desarrollo , Materiales Biomédicos y Dentales/química , Materiales Biomédicos y Dentales/farmacología , Tampones (Química) , Placa Dental/microbiología , Placa Dental/prevención & control , Ecosistema , Ácido Edético/química , Ácido Edético/farmacología , Concentración de Iones de Hidrógeno , Interacciones Microbianas/efectos de los fármacos , Interacciones Microbianas/fisiología , Micrococcus luteus/efectos de los fármacos , Micrococcus luteus/fisiología , Microscopía Confocal , Concentración Osmolar , Sales (Química)/química , Sales (Química)/farmacología , Cloruro de Sodio/química , Cloruro de Sodio/farmacología , Sphingomonas/efectos de los fármacos , Sphingomonas/fisiología , Temperatura , Trometamina/química , Trometamina/farmacología , ViscosidadRESUMEN
In this work, we report a convenient method of grafting non-leachable bioactive amine functions onto the surface of bacterial cellulose (BC) nanofibrils, via a simple silylation treatment in water. Two different silylation protocols, involving different solvents and post-treatments were envisaged and compared, using 3-aminopropyl-trimethoxysilane (APS) and (2-aminoethyl)-3-aminopropyl-trimethoxysilane (AEAPS) as silylating agents. In aqueous and controlled conditions, water-leaching resistant amino functions could be successfully introduced into BC, via a simple freeze-drying process. The silylated material remained highly porous, hygroscopic and displayed sufficient thermal stability to support the sterilization treatments generally required in medical applications. The impact of the silylation treatment on the intrinsic anti-bacterial properties of BC was investigated against the growth of Escherichia coli and Staphylococcus aureus. The results obtained after the in vitro studies revealed a significant growth reduction of S. aureus within the material.
Asunto(s)
Materiales Biomédicos y Dentales , Celulosa/farmacología , Gluconacetobacter/metabolismo , Membranas/química , Nanofibras , Silanos/química , Antibacterianos/farmacología , Materiales Biomédicos y Dentales/química , Materiales Biomédicos y Dentales/farmacología , Escherichia coli/efectos de los fármacos , Nanofibras/química , Nanofibras/uso terapéutico , Staphylococcus aureus/efectos de los fármacosRESUMEN
This paper critically reviews the current evidence of research in biomedical applications of selenium nanoparticles (SeNPs) and their effects at cellular and tissue levels. In recent years, interest in SeNPs as a natural trace element nanomaterial for nanomedicine has resulted in a number of studies evaluating their bioactivities, such as anticancer, antimicrobial, and antioxidant properties. Significant data have been generated to demonstrate the effectiveness of SeNPs alone or in combination with other reagents. Their activities are demonstrated through in vitro and in vivo experimentation; yet, the levels of efficacy need to be improved, particularly when compared with those of pharmaceutical drugs (such as antibiotics and cytotoxic chemotherapeutic drugs). However, promising evidence suggests decreased toxicity when using SeNPs, and more importantly their ability to perform as an interfacing biomaterial with cells and tissues. SeNPs have demonstrated unique antibacterial properties: they inhibit bacterial adhesion, growth, and/or quorum sensing and as a result prevent biofilm formation on medical devices, to name a few. Therefore, as with other nanomaterials, SeNPs warrant further study as part of the biomaterial-based therapeutic toolkit as an alternative to traditional pharmaceutical agents. This paper will provide a succinct review of recent studies on SeNPs to critically assess the findings in the light of effectiveness, particularly highlighting the roles of the cellular interface. Finally, an outlook of the potential of SeNPs will be presented to highlight the need for more intensive studies of material stability, mechanistic understanding at subcellular levels, and investigations into their combinational and/or synergistic effects with other bioactive reagents including pharmaceutical drugs.
Asunto(s)
Antiinfecciosos/farmacología , Antineoplásicos/farmacología , Antioxidantes/farmacología , Materiales Biomédicos y Dentales/farmacología , Nanopartículas/metabolismo , Selenio/farmacología , Oligoelementos/farmacología , Animales , Antiinfecciosos/uso terapéutico , Antineoplásicos/uso terapéutico , Antioxidantes/uso terapéutico , Bacterias/efectos de los fármacos , Biopelículas/efectos de los fármacos , Materiales Biomédicos y Dentales/uso terapéutico , Células/efectos de los fármacos , Humanos , Nanomedicina/métodos , Nanopartículas/uso terapéutico , Percepción de Quorum/efectos de los fármacos , Selenio/uso terapéutico , Oligoelementos/uso terapéuticoRESUMEN
The present study aimed to investigate the periodontal regenerative effect of enamel matrix derivative (EMD) in diabetes. Thirty-six rats were assigned to streptozotocin-induced diabetes or control (non-diabetic) groups. Three-wall intrabony defects were surgically generated in the bilateral maxilla molar, followed by application of EMD or saline. Primary wound closure and defect fill were evaluated via histomorphological analysis and micro-computed tomography. mRNA expression levels of inflammatory and angiogenic factors in the defects were quantified via real-time polymerase chain reaction. Gingival fibroblasts were isolated from control animals and cultured in high-glucose (HG) or control medium. The effects of EMD on insulin resistance and PI3K/Akt/VEGF signaling were evaluated. The achievement rate of primary closure and the parameters of defect fill were significantly higher at EMD-treated site than at EMD-untreated sites in both diabetic and non-diabetic rats, although defect fill in the diabetic groups was significantly lower in the control groups on two-way repeated-measures analysis of variance (for both, p<0.05). Newly formed bone and cementum were significantly increased at EMD-treated sites in diabetic rats than at EMD-untreated sites in control rats (for both, p<0.05). Vegf was significantly upregulated at EMD-treated sites in both diabetic and non-diabetic rats (for both, p<0.05). In vitro, insulin or EMD-induced Akt phosphorylation was significantly lower in cells cultured in HG medium (p<0.05). EMD-mediated Vegf upregulation was suppressed by the Akt inhibitor wortmannin, although the effect was significantly lower in HG medium (p<0.01). In conclusion, EMD might promote periodontal tissue regeneration via Akt/VEGF signaling, even in a diabetic condition.
Asunto(s)
Materiales Biomédicos y Dentales/farmacología , Proteínas del Esmalte Dental/farmacología , Esmalte Dental/efectos de los fármacos , Diabetes Mellitus Experimental/tratamiento farmacológico , Regeneración/efectos de los fármacos , Animales , Células Cultivadas , Esmalte Dental/fisiopatología , Diabetes Mellitus Experimental/diagnóstico por imagen , Diabetes Mellitus Experimental/patología , Diabetes Mellitus Experimental/fisiopatología , Fibroblastos/efectos de los fármacos , Fibroblastos/fisiología , Encía/diagnóstico por imagen , Encía/efectos de los fármacos , Encía/fisiopatología , Hipoglucemiantes/farmacología , Resistencia a la Insulina , Masculino , Diente Molar , Fosfatidilinositol 3-Quinasas/metabolismo , Proteínas Proto-Oncogénicas c-akt/metabolismo , ARN Mensajero/metabolismo , Ratas Wistar , Regeneración/fisiología , Factor A de Crecimiento Endotelial Vascular/metabolismoRESUMEN
We describe a model which can be used for in vitro biocompatibility assays of biomaterials. We studied the in vitro response of human osteoarthritis or rheumatoid arthritis fibroblast-like synoviocytes to Al2O3 or ZrO2 particles by analysing the production of interleukin-1 (IL-1) and interleukin-6 (IL-6) and the metabolism of arachidonic acid via lipoxygenase and cyclo-oxygenase pathways. Our results show that, in these cells and under our experimental conditions, Al2O3 and ZrO2 did not significantly modify the synthesis of IL-1 and IL-6 or the metabolism of arachidonic acid.
Asunto(s)
Óxido de Aluminio/farmacología , Ácido Araquidónico/metabolismo , Materiales Biomédicos y Dentales/farmacología , Células del Tejido Conectivo/efectos de los fármacos , Células del Tejido Conectivo/fisiología , Interleucina-1/biosíntesis , Interleucina-6/biosíntesis , Ensayo de Materiales/métodos , Circonio/farmacología , Artritis Reumatoide/inmunología , Materiales Biocompatibles/farmacología , Técnicas de Cultivo de Célula , Dinoprostona/biosíntesis , Eicosanoides/biosíntesis , Humanos , Inflamación/inmunología , Modelos Biológicos , Osteoartritis/inmunologíaRESUMEN
Nanotechnology is a new field of science and technology that has already had significant impact in the development of novel products in industry. In medicine, application of nanotechnology has the potential to develop new imaging agents, pharmaceutical drugs and medical devices with unique physical and chemical properties. This article reviews the potential for various nanoparticles in cardiovascular imaging and therapeutics, nanoporous structures for sensing and implant based drug delivery, and self-assembled monolayers for surface modification and implant based drug delivery.